Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-7.54

-6.66

-5.79

-4.92

Details

Expected EPS

-7.536514

Actual EPS

-7.1

Surprise EPS

0.44

Surprise Percent

+5.79%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -7.1 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.